Skip to main content
. 2015 Mar 19;4(6):e1009285. doi: 10.1080/2162402X.2015.1009285

Figure 2.

Figure 2.

Survival analysis of MPM epithelioid patients according to the presence of tumor-associated macrophages and lymphocytes. Kaplan-Meier survival analysis of of malignant pleural mesothelioma (MPM) patients (n = 230) according to the indicated tumor-associated macrophage marker (CD163) and T and B lymphocytes (CD8 and CD20, respectively). Overall survival (OS) by (A) tumoral CD163/CD8 combinations, and (B) tumoral CD163/CD20 combinations.